Kuros Biosciences AG (KURN) - Stock & Dividends

Exchange: SIX Swiss Exchange • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH0325814116

Bone Grafts, Pharmaceuticals, Medical Devices

Kuros Biosciences AG is a biopharmaceutical company that specializes in developing innovative solutions for tissue repair and bone regeneration. The company operates globally, with a presence in the United States, the European Union, and other international markets.

The company's product portfolio is divided into three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. Its flagship product, MagnetOs, is a groundbreaking bone graft system that utilizes submicron needle-shaped NeedleGrip surface technology to promote bone growth and fusion.

Within the MagnetOs family, the company offers a range of products, including MagnetOs Granules, a versatile bone graft material; MagnetOs Putty, a moldable putty for filling bony voids; MagnetOs Easypack Putty, a ready-to-use putty for intervertebral disc and posterolateral spine procedures; and Magnetos Flex Matrix, an open matrix bone graft for complex bone defects.

In addition to its commercialized products, Kuros Biosciences has a promising pipeline of Fibrin-PTH products in various stages of clinical development. KUR-111 and KUR-113 are currently in Phase 2b clinical trials for trauma indications, while KUR-113 is also being evaluated in a Phase 2a clinical trial for spinal indications.

Founded in 2016, Kuros Biosciences is headquartered in Schlieren, Switzerland, and is committed to improving patient outcomes through innovative tissue repair and bone regeneration solutions. For more information, please visit the company's website at https://www.kuros.ch.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Kuros Biosciences AG (KURN) - Stock & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Kuros Biosciences AG (KURN) - Stock & Dividends

KURN Stock Overview

Market Cap in USD 321m
Sector Healthcare
Industry Medical Devices
GiC SubIndustry Health Care Equipment
TER 0.00%
IPO / Inception

KURN Stock Ratings

Growth 5y 51.5
Fundamental -51.6
Dividend -
Rel. Performance vs Sector 20.42
Analysts -
Fair Price Momentum 25.42 CHF
Fair Price DCF -

KURN Dividends

Yield 12m 0.00%
Yield on Cost 5y 0.00%
Dividends CAGR 5y 0.00%
Payout Consistency 0.0%

KURN Growth Ratios

Growth 12m 855.20%
Growth Correlation 12m 85%
Growth Correlation 3m 76%
CAGR 5y 44.79%
CAGR/Mean DD 5y 1.36
Sharpe Ratio 12m 10.19
Alpha vs SP500 12m 841.25
Beta vs SP500 5y weekly 0.45
ValueRay RSI 91.29
Volatility GJR Garch 1y 91.97%
Price / SMA 50 49.44%
Price / SMA 200 143.67%
Current Volume 262.3k
Average Volume 20d 282.3k

External Links for KURN Stock

Fund Manager Positions
What is the price of KURN stocks?
As of June 15, 2024, the stock is trading at CHF 11.94 with a total of 262,261 shares traded.
Over the past week, the price has changed by +15.25%, over one month by +64.92%, over three months by +118.68% and over the past year by +794.38%.
What are the forecast for KURN stock price target?
According to ValueRays Forecast Model, KURN Kuros Biosciences AG will be worth about 27.9 in June 2025. The stock is currently trading at 11.94. This means that the stock has a potential upside of +134%.
Issuer Forecast Upside
Wallstreet Target Price 20.1 67.9
Analysts Target Price - -
ValueRay Target Price 27.9 134